Cellular localization and expression patterns of interleukin-10, interleukin-4, and their receptors in multiple sclerosis lesions

GLIA

Volumn 38, Issue 1, 2002, Pages 24-35

  Hulshof, Sandra ^a   Montagne, Lisette ^a   De Groot, Corline J A ^a   Van Valk, Paul Der ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti inflammatory cytokines; Astrocytes; Central nervous system; Macrophages; Multiple sclerosis; Receptors

Indexed keywords

CYTOKINE RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN; CELL CULTURE; DRUG EFFECT; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MACROPHAGE; MALE; METABOLISM; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELINATED NERVE; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ASTROCYTES; BRAIN; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; INTERLEUKIN-4; MACROPHAGES; MALE; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; RECEPTORS, CYTOKINE; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-10; RECEPTORS, INTERLEUKIN-4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036544764     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.10050     Document Type: Article

References (49)

1. Lung epithelial barrier function and wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-γ
2. IL-12 production by central nervous system microgila is inhibited by astrocytes
3. Oral or intravenous methylprednisolone for acute relapses of MS?
4. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: Do cytokines trigger off exacerbations?
5. Biology of TGF-beta in knockout and transgenic mouse models
6. Functions of IL-4 and control of its expression
7. Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS
8. The adhesion molecule and cytokine profile of multiple sclerosis lesions
9. IL-10 fails to abrogate experimental autoimmune encephalomyelitis
10. Balancing function vs. self defense: The CNS as an active regulator of immune responses
11. IL-10 mediated suppression of TNFα production is independent of its ability to inhibit NF-κB activity
12. Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system
13. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis
14. Establishment of human adult astrocyte cultures derived from postmortem multiple sclerosis and control brain and spinal cord regions: Immunophenotypical and functional characterization
15. Expression of transforming growth factor (TGF)-β1, -β2 and -β3 isoforms and TGF-β type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures
16. Isolation and characterization of adult microglial cells and oligodendrocytes derived from postmortem human brain tissue
17. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions. Increased yield of active demyelinating and (p) reactive lesions
18. Establishment of microglial cell cultures derived from postmortem human adult brain tissue: Immunophenotypical and functional characterization
19. Induction of interleukin-1 and interleukin-1 receptor antagonist
20. Interleukin-4 down-regulates adult human astrocyte DNA synthesis and proliferation
21. IL-4 suppresses cytokine gene expression induced by IFN-γ and/or IL-2 in murine peritoneal macrophages
22. Tumor necrosis factor alfa but not lymphotoxin is overproduced by blood mononuclear cells in multiple sclerosis
23. A receptor for interleukin-10 is related to interferon receptors
24. Interleukin-1β induced cyclooxygenase 2 expression and prostagladin E2 secrestion by human neuroblastoma cells: Implications for Alzheimer's disease
25. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily
26. In vivo administration of IL-4 induces TGF-beta-producing cells and protects animals from experimental autoimmune encephalomyelitis
27. Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus)
28. Expression cloning and characterization of a human IL-10 receptor
29. Characterization of tumor necrosis factor-deficient mice
30. Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: A novel gene therapy approach
31. Cytokines in inflammatory brain lesions helpful and harmful
32. Production of interleukin-10 by mouse glial cells in culture
33. Interleukin-10
34. Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis
35. Exacerbations of multiple sclerosis in patients treated with gamma interferon
36. Cytokines in Alzheimer's disease and multiple sclerosis
37. Cytokines and the brain
38. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis
39. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity
40. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis
41. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
42. Immune deviation following pulse cyclophosphamide/methylprednisolone treatment of multiple sclerosis: Increased interleukin-4 production and associated eosinophilia
43. Suppression of concanavalin A-induced hepatitis in IFN-gamma (-/-) mice, but not in TNF-alpha (-/-) mice: Role for IFN-gamma in activating apoptosis of hepatocytes
44. Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor α and human IL-6 by human monocytes
45. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis
46. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis
47. Transforming growth factor-beta1 induces apoptosis of rat microglia without relation to bcl-2 oncoprotein expression
48. Supression of acute and protacted-relapsing experimental encephalomyelitis by nasal administration of low-dose IL-10 in rats
49. Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies?